Table 2 irAEs for treatment type (FMT-related only and FMT in combination with ICI-based therapy)

From: Fecal microbiota transplantation plus immunotherapy in metastatic renal cell carcinoma: the phase 1 PERFORM trial

Adverse events likely caused by FMT

Number of events/number of patients with an adverse event

Overall

Grade 1

Grade 2

Grade 3

Overall

Diarrhea

1/1

0/0

0/0

1/1

Adverse events likely caused by immunotherapy treatment

Number of events/number of patients with an adverse event

 

Grade 1

Grade 2

Grade 3

Overall

Overall

32/12

29/12

18/10

79/17

Colitis

0/0

3/2

7/6

10/6

Diarrhea

4/4

3/2

4/3

11/7

Fatigue

7/4

3/2

1/1

11/5

Immune-related pain

2/2

4/3

1/1

7/4

Rash/pruritis/urticaria

8/5

2/2

1/1

11/8

Anorexia

3/3

2/2

1/1

6/5

Arthritis

0/0

1/1

1/1

2/2

Transaminitis

1/1

0/0

1/1

2/2

Hypothyroidism

0/0

2/2

0/0

2/2

Hyponatremia

1/1

0/0

0/0

1/1

Dry mouth/mucositis

2/2

1/1

0/0

3/2

Hyperglycemia

0/0

1/1

1/1

2/2

Hot flashes

0/0

1/1

0/0

1/1

Nausea

1/1

1/1

0/0

2/1

Pneumonitis

1/1

1/1

0/0

2/1

Adrenal insufficiency

0/0

1/1

0/0

1/1

Dyspnea

2/2

1/1

0/0

3/2

Gastrointestinal disorders

0/0

1/1

0/0

1/1

Infusion-related reaction

0/0

1/1

0/0

1/1